Clinical Trials
3 trialsNCT00268918 2018-07-27
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00216047 2015-12-09
PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 1/2 Terminated
NCT00263198 2013-05-07
PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer
Washington University School of Medicine
Phase 2 Terminated